These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 8430067)

  • 1. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
    Dahlbäck B; Carlsson M; Svensson PJ
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1004-8. PubMed ID: 8430067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.
    Dahlbäck B; Hildebrand B
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1396-400. PubMed ID: 8108421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to activated protein C: evaluation of three functional assays.
    Vasse M; Leduc O; Borg JY; Chrétien MH; Monconduit M
    Thromb Res; 1994 Oct; 76(1):47-59. PubMed ID: 7817360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):51-7. PubMed ID: 8180338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
    Toulon P; Perez P
    Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C.
    Kraus M; Zander N; Fickenscher K
    Thromb Res; 1995 Nov; 80(3):255-64. PubMed ID: 8578552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilia: a new factor emerges from the mists.
    Tuddenham EG
    Lancet; 1993 Dec 18-25; 342(8886-8887):1501-2. PubMed ID: 7902896
    [No Abstract]   [Full Text] [Related]  

  • 10. A chromogenic assay for activated protein C resistance.
    Váradi K; Moritz B; Lang H; Bauer K; Preston E; Peake I; Rivard GE; Keil B; Schwarz HP
    Br J Haematol; 1995 Aug; 90(4):884-91. PubMed ID: 7669667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
    Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G
    J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial thrombophilia: clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency.
    Zöller B
    Scand J Clin Lab Invest Suppl; 1996; 226():19-46. PubMed ID: 8981666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy?
    Cook G; Walker ID; McCall F; Conkie JA; Greer IA
    Br J Haematol; 1994 Aug; 87(4):873-5. PubMed ID: 7986734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.
    Dahlbäck B
    Int J Lab Hematol; 2016 May; 38 Suppl 1():4-11. PubMed ID: 27161771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant response to activated protein C: method validation and assay comparison.
    Calkins T; Greengard J; Griffin JH; Bylund D
    J Clin Lab Anal; 1995; 9(6):418-23. PubMed ID: 8587012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.
    Koster T; Rosendaal FR; de Ronde H; Briët E; Vandenbroucke JP; Bertina RM
    Lancet; 1993 Dec 18-25; 342(8886-8887):1503-6. PubMed ID: 7902898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anticoagulant response to activated protein C in patients with IDDM.
    Krugluger W; Kopp HP; Schernthaner G; Hopmeier P
    Diabetes; 1995 Sep; 44(9):1033-7. PubMed ID: 7657025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.